NIH-funded research R21 grant

Exploring how cannabidiol laws affect substance use behaviors

Official title: Understanding cannabidiol policy and its impacts on broader substance use

Funded at Rand Corporation · NIH-11160963 · Data updated 2026-11-12

This study looks at how changes in laws about CBD (a compound found in cannabis) affect people's use of alcohol and opioids, helping us understand if having access to CBD for medical reasons can lead to less misuse of stronger painkillers and fewer overdoses.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRand Corporation
NIH-funded
Lab location1 site (Santa Monica, United States)
Project startApril 15, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$268,470
NIH project number1R21DA060486-01A1
Project IDNIH-11160963 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals over 21 years old who are using or considering using CBD products.

Less likely to help

Patients who do not use CBD or are not affected by substance use issues may not benefit from this research.

What this research studies

This research investigates the impact of cannabidiol (CBD) policy changes on substance use behaviors, particularly focusing on alcohol and opioid use. It aims to understand how the legalization of medical CBD in various states influences public health outcomes, including rates of substance use and related poisonings. By analyzing the relationship between CBD access and changes in substance use, the study seeks to provide insights into how alternative pain management options may affect opioid misuse and overdose rates. The research will utilize data from states with varying CBD laws to assess these impacts.

Why it matters

Potential benefit: If successful, this research could inform policies that improve public health by reducing substance misuse and related harms.

How similar studies have gone: Previous research has shown that marijuana policies can influence alcohol and opioid use, suggesting potential for similar findings with CBD policies.

Where this research is happening

  • Rand Corporation
    Santa Monica, United States
    Active

Researchers

  • Principal investigator: Powell, David — Rand Corporation
  • Study coordinator: Powell, David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.